The immunoenzymatic assay is intended for the diagnosis of parvovirus B19 infections using IgM antibodies in human serum or plasma in the general population. The semi-quantitative manual assay is designed for professional use in a laboratory.
Description:
Antigen used is VP2 recombinant protein.
If specific antibodies are present, they bind to the antigen, are labeled by the Conjugate in the following steps and are detected by color reaction with a single component substrate (TMB-Complete).
The kit allows 96 tests, including controls in a split microtiter plate with color-coded strips and breakable wells.
Advantages:
The total assay time is about 2 hours.
High sensitivity and specificity of the test.
Kit includes CUT-OFF, Positive Control and Negative Control, Calibrators.
Semi-quantitative evaluation in the Index of Positivity (IP).
Ready-to-use, color-coded components.
Single-component substrate.
Interchangeable components with the exception of kit specific components (Controls, Conjugate, Plate).
Sample diluent contains IgG/RF sorbent.
Application:
Determination of specific IgM antibodies in human serum or plasma.
Semiquantitative evaluation is suitable for the therapy success follow-up.
Disease stage evaluation.